Farms.com Home   News

Soybean Replant Considerations

Soybeans are prone to poor plant establishment because the seedling must pull the cotyledon seed leaves through the ground to emerge. Plant stand reductions are rarely uniform, which makes the decision to replant difficult. Do not assess a poor soybean stand too quickly, since more seedlings may still emerge. In 2020 we have seen soybeans emerge 40 days after planting. Amazingly, many April planted soybeans that suffered from extreme cold now have excellent plant stands. Often once a crack is visible on the soil surface down the row a sufficient number of seedlings will survive.
 
A plant reduction of up to 50% does not need replanting if plant loss is uniform and the stand is healthy. Numerous studies and field experience have demonstrated that keeping an existing stand is often more profitable than replanting. Replanting gives no guarantee of a perfect stand. Keep in mind that normal seeding rates include a margin of safety to ensure emergence of an adequate stand.
 
Understanding the cause of the low plant population is essential to know if replanting is necessary. These include soil crusting, herbicide injury, frost, hail, insects and diseases. For instance, if seed corn maggot has reduced the stand many of the surviving seedlings will also be partially destroyed. Replanting in that case is usually the correct decision because the remaining plants are also weakened, and an insecticide seed treatment is necessary when replanting. In a wet year, damping-off may be the issue. In this situation consider the use of a variety resistant to Phytophthora plus a fungicide seed treatment when replanting.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.